Last year, Keytruda also failed the KEYNOTE-921 study of Keytruda plus chemotherapy in mCRPC previously treated with hormonal therapies, and the KEYLYNK-010 trial of a combination of Keytruda and ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its GLP ... top quarter of biotech IPOs last year, and the largest of ...

In Republic Day speech, governor makes announcements on plans for city; boost to Metro service and other infra developments coming up The phase three Metro projects including corridors one and two ...

Need a break? Play the USA TODAY Daily Crossword Puzzle. Three posters for "The Last of Us" Season 2 were released alongside the premiere date. One shows Joel standing on top of the broken watch ...

Ionis (IONS) partner Novartis (NVS) shared in their year-end earnings report that Phase 3 pelacarsen data is now expected in the first half of 2026 with subsequent regulatory submissions in the ...

"We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the Phase 3 SOTERIA open-label ...

Dubois has now claimed that he didn't pick Parker to win any of his last three fights. The Kiwi told DAZN: You know when you've done everything there is and you can't do anymore to prepare?

Friday is the last day of a survey to collect information ... various parts of town at the peak periods from 8 to 9 a.m. and 3 to 4 p.m. It found an average of 2,083 vehicles in the morning ...

NEW YORK, February 03, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

If you’re a Baldur’s Gate 3 player on PlayStation 5, you can check out the game’s long-awaited Patch 8 ahead of schedule. And the developers have no idea why. “No, the Patch 8 stress test ...

with the tolerability profile of the drug consistent with the phase 2 FRONTIER 1 and 2 studies reported last year. There was little difference between icotrokinra and placebo on safety, with 49.3% ...